Faculty, Staff and Student Publications
Publication Date
6-17-2024
Journal
Drug Metabolism and Disposition
DOI
10.1124/dmd.124.001719
PMID
38658163
PMCID
PMC11185819
PubMedCentral® Posted Date
7-1-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Imaging mass spectrometry (IMS) is a powerful tool for mapping the spatial distribution of unlabeled drugs and metabolites that may find application in assessing drug delivery, explaining drug efficacy, and identifying potential toxicity. This study focuses on determining the spatial distribution of the antidepressant duloxetine, which is widely prescribed despite common adverse effects (liver injury, constant headaches) whose mechanisms are not fully understood. We used high-resolution IMS with matrix-assisted laser desorption/ionization to examine the distribution of duloxetine and its major metabolites in four mouse organs where it may contribute to efficacy or toxicity: brain, liver, kidney, and spleen. In none of these tissues is duloxetine or its metabolites homogeneously distributed, which has implications for both efficacy and toxicity. We found duloxetine to be similarly distributed in spleen red pulp and white pulp but differentially distributed in different anatomic regions of the liver, kidney, and brain, with dose-dependent patterns. Comparison with hematoxylin and eosin staining of tissue sections reveals that the ion images of endogenous lipids help delineate anatomic regions in the brain and kidney, while heme ion images assist in differentiating regions within the spleen. These endogenous metabolites may serve as a valuable resource for examining the spatial distribution of other drugs in tissues when staining images are not available. These findings may facilitate future mechanistic studies of the therapeutic and adverse effects of duloxetine. In the current work, we did not perform absolute quantification of duloxetine, which will be reported in due course. SIGNIFICANCE STATEMENT: The study utilized imaging mass spectrometry to examine the spatial distribution of duloxetine and its primary metabolites in mouse brain, liver, kidney, and spleen. These results may pave the way for future investigations into the mechanisms behind duloxetine's therapeutic and adverse effects. Furthermore, the mass spectrometry images of specific endogenous metabolites such as heme could be valuable in analyzing the spatial distribution of other drugs within tissues in scenarios where histological staining images are unavailable.
Keywords
Animals, Duloxetine Hydrochloride, Mice, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Spleen, Brain, Kidney, Liver, Antidepressive Agents, Tissue Distribution, Male, Mice, Inbred C57BL
Published Open-Access
yes
Recommended Citation
Khalil, Saleh M; Qin, Xuan; Hakenjos, John M; et al., "Maldi Imaging Mass Spectrometry Visualizes the Distribution of Antidepressant Duloxetine and Its Major Metabolites in Mouse Brain, Liver, Kidney, and Spleen Tissues" (2024). Faculty, Staff and Student Publications. 991.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/991
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Structures Commons, Genomics Commons, Medical Genetics Commons, Oncology Commons